Key facts
- This page summarizes Sandro Galea's Form 4 filing for Sharecare, Inc..
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 14 Jun 2022, 20:52.
Sandro Galea - 10 Jun 2022 Form 4 Insider Report for Sharecare, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 10 Jun 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 14 Jun 2022, 20:52:03 UTC
- Prior SEC filing
- 09 Sep 2021
- Next SEC filing
- 10 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christie J. Miller, Attorney-in-Fact for Reporting Person
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Sandro Galea filed Form 4 for Sharecare, Inc. on 14 Jun 2022.
Change
- Previous filing in this sequence was filed on 09 Sep 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SHCR
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +19,000
- Change %
- Price
- Shares after
- 19,000
- Date
- 10 Jun 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SHCR
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -19,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 10 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 19,000
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Filed to report vesting of Restricted Stock Units ("RSUs"). RSUs converted into common stock on a one-for-one basis.
Footnote F2
On September 7, 2021, the Reporting Person was granted 19,000 RSUs, which vest on the earlier of (i) the first annual meeting of the Company's stockholders following the grant date and (ii) July 1, 2022, subject to the Reporting Person's continued service as a director of the Company. The first annual meeting of the Company's stockholders was held on June 10, 2022.